Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
64.12
-0.06 (-0.09%)
Nov 21, 2024, 1:10 PM EST - Market open
Utah Medical Products Revenue
Utah Medical Products had revenue of $10.01M in the quarter ending September 30, 2024, a decrease of -19.99%. This brings the company's revenue in the last twelve months to $44.08M, down -14.35% year-over-year. In the year 2023, Utah Medical Products had annual revenue of $50.22M, down -3.93%.
Revenue (ttm)
$44.08M
Revenue Growth
-14.35%
P/S Ratio
5.19
Revenue / Employee
$231,989
Employees
190
Market Cap
217.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 50.22M | -2.06M | -3.93% |
Dec 31, 2022 | 52.28M | 3.23M | 6.58% |
Dec 31, 2021 | 49.05M | 6.88M | 16.30% |
Dec 31, 2020 | 42.18M | -4.73M | -10.08% |
Dec 31, 2019 | 46.90M | 4.91M | 11.68% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
High Tide | 370.02M |
Inogen | 331.52M |
biote | 193.06M |
Sutro Biopharma | 160.96M |
Genfit | 86.23M |
SOPHiA GENETICS | 64.49M |
Zentalis Pharmaceuticals | 40.56M |
TScan Therapeutics | 9.36M |
UTMD News
- 16 days ago - Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend - Accesswire
- 23 days ago - UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024 - Accesswire
- 3 months ago - Utah Medical Products, Inc. Announces Quarterly Dividend - Accesswire
- 4 months ago - UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024 - Accesswire
- 7 months ago - Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024 - Accesswire
- 10 months ago - UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance - GlobeNewsWire
- 1 year ago - Utah Medical Products, Inc. Increases Regular Quarterly Dividend - Accesswire
- 1 year ago - UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023 - GlobeNewsWire